Zinc finger protein 467 regulates Wnt signaling by modulating the expression of sclerostin in adipose derived stem cells

Biochemical and Biophysical Research Communications

Volumn 456, Issue 2, 2015, Pages 598-604

  You, Li ^a   Chen, Lin ^a   Pan, Ling ^a   Gu, Wen Sha ^a   Chen, Jin Yu ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

ADSCs; Sost; Wnt signaling; Zfp467

Indexed keywords

REGULATOR PROTEIN; SCLEROSTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 467; DNA BINDING PROTEIN; GLYCOPROTEIN; SOST PROTEIN, MOUSE; ZINC FINGER PROTEIN 467, MOUSE;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; COMPLEX FORMATION; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; WNT SIGNALING PATHWAY; ADIPOSE TISSUE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; OSTEOPOROSIS; PROMOTER REGION; STEM CELL;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; GLYCOPROTEINS; MICE; OSTEOBLASTS; OSTEOPOROSIS; PROMOTER REGIONS, GENETIC; STEM CELLS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84919916572     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.120     Document Type: Article

References (33)

1. M.S. Nanes, and C.B. Kallen Osteoporosis Semin. Nucl. Med. 44 2014 439 450
2. Y. Wang, and D.W. Grainger Developing siRNA therapies to address osteoporosis Ther. Deliv. 4 2013 1239 1246
3. J.Y. Reginster, and N. Burlet Osteoporosis: a still increasing prevalence Bone 38 2006 S4 9
4. J. Justesen, K. Stenderup, E.F. Eriksen, and M. Kassem Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures Calcif. Tissue Int. 71 2002 36 44
5. J.P. Rodriguez, P. Astudillo, S. Rios, and A.M. Pino Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis Curr. Stem Cell Res. Ther. 3 2008 208 218
6. H.Y. Liu, J.F. Chiou, A.T. Wu, C.Y. Tsai, J.D. Leu, L.L. Ting, M.F. Wang, H.Y. Chen, C.T. Lin, D.F. Williams, and W.P. Deng The effect of diminished osteogenic signals on reduced osteoporosis recovery in aged mice and the potential therapeutic use of adipose-derived stem cells Biomaterials 33 2012 6105 6112
7. S.E. Papapoulos Targeting sclerostin as potential treatment of osteoporosis Ann. Rheum. Dis. 70 Suppl. 1 2011 i119 122
8. R.L. van Bezooijen, B.A. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, M. Karperien, H. Hamersma, S.E. Papapoulos, P. ten Dijke, and C.W. Lowik Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J. Exp. Med. 199 2004 805 814
9. R.L. van Bezooijen, P. ten Dijke, S.E. Papapoulos, and C.W. Lowik SOST/sclerostin, an osteocyte-derived negative regulator of bone formation Cytokine Growth Factor Rev. 16 2005 319 327
10. M. Semenov, K. Tamai, and X. He SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor J. Biol. Chem. 280 2005 26770 26775
11. J.M. Martinez-Moreno, J.R. Munoz-Castaneda, C. Herencia, A.M. Oca, J.C. Estepa, R. Canalejo, M.E. Rodriguez-Ortiz, P. Perez-Martinez, E. Aguilera-Tejero, A. Canalejo, M. Rodriguez, and Y. Almaden In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation Am. J. Physiol. Renal Physiol. 303 2012 F1136 1144
12. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
13. L. You, L. Pan, L. Chen, J.Y. Chen, X. Zhang, Z. Lv, and D. Fu Suppression of zinc finger protein 467 alleviates osteoporosis through promoting differentiation of adipose derived stem cells to osteoblasts J. Transl. Med. 10 2012 11
14. J.M. Quach, E.C. Walker, E. Allan, M. Solano, A. Yokoyama, S. Kato, N.A. Sims, M.T. Gillespie, and T.J. Martin Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment J. Biol. Chem. 286 2011 4186 4198
15. K. Nakayama, K.W. Kim, and A. Miyajima A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3 EMBO J. 21 2002 6174 6184
16. P.A. Zuk, M. Zhu, H. Mizuno, J. Huang, J.W. Futrell, A.J. Katz, P. Benhaim, H.P. Lorenz, and M.H. Hedrick Multilineage cells from human adipose tissue: implications for cell-based therapies Tissue Eng. 7 2001 211 228
17. C. Zhang, W. Tang, Y. Li, F. Yang, D.R. Dowd, and P.N. MacDonald Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts PLoS One 6 2011 e26504
18. S.C. Hsu, J. Galceran, and R. Grosschedl Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin Mol. Cell Biol. 18 1998 4807 4818
19. E. Cohen-Kfir, H. Artsi, A. Levin, E. Abramowitz, A. Bajayo, I. Gurt, L. Zhong, A. D'Urso, D. Toiber, R. Mostoslavsky, and R. Dresner-Pollak Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor Endocrinology 152 2011 4514 4524
20. F. Yang, W. Tang, S. So, B. de Crombrugghe, and C. Zhang Sclerostin is a direct target of osteoblast-specific transcription factor osterix Biochem. Biophys. Res. Commun. 400 2010 684 688
21. J. Papkoff, B. Rubinfeld, B. Schryver, and P. Polakis Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes Mol. Cell Biol. 16 1996 2128 2134
22. F. Veronesi, P. Torricelli, V. Borsari, M. Tschon, L. Rimondini, and M. Fini Mesenchymal stem cells in the aging and osteoporotic population Crit. Rev. Eukaryot. Gene Expr. 21 2011 363 377
23. P. Benisch, T. Schilling, L. Klein-Hitpass, S.P. Frey, L. Seefried, N. Raaijmakers, M. Krug, M. Regensburger, S. Zeck, T. Schinke, M. Amling, R. Ebert, and F. Jakob The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors PLoS One 7 2012 e45142
24. F. Jakob, R. Ebert, A. Ignatius, T. Matsushita, Y. Watanabe, J. Groll, and H. Walles Bone tissue engineering in osteoporosis Maturitas 75 2013 118 124
25. Y.D. Halvorsen, D. Franklin, A.L. Bond, D.C. Hitt, C. Auchter, A.L. Boskey, E.P. Paschalis, W.O. Wilkison, and J.M. Gimble Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells Tissue Eng. 7 2001 729 741
26. M. Knippenberg, M.N. Helder, B.Z. Doulabi, C.M. Semeins, P.I. Wuisman, and J. Klein-Nulend Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation Tissue Eng. 11 2005 1780 1788
27. J.L. Dragoo, J.Y. Choi, J.R. Lieberman, J. Huang, P.A. Zuk, J. Zhang, M.H. Hedrick, and P. Benhaim Bone induction by BMP-2 transduced stem cells derived from human fat J. Orthop. Res. 21 2003 622 629
28. M. Knippenberg, M.N. Helder, B. Zandieh Doulabi, P.I. Wuisman, and J. Klein-Nulend Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells Biochem. Biophys. Res. Commun. 342 2006 902 908
29. P. Zuk, Y.F. Chou, F. Mussano, P. Benhaim, and B.M. Wu Adipose-derived stem cells and BMP2: part 2. BMP2 may not influence the osteogenic fate of human adipose-derived stem cells Connect. Tissue Res. 52 2011 119 132
30. H.H. Cho, H.T. Park, Y.J. Kim, Y.C. Bae, K.T. Suh, and J.S. Jung Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors J. Cell Biochem. 96 2005 533 542
31. H.S. Lee, H.H. Cho, H.K. Kim, Y.C. Bae, H.S. Baik, and J.S. Jung Tbx3, a transcriptional factor, involves in proliferation and osteogenic differentiation of human adipose stromal cells Mol. Cell Biochem. 296 2007 129 136
32. N. Kakudo, A. Shimotsuma, S. Miyake, S. Kushida, and K. Kusumoto Bone tissue engineering using human adipose-derived stem cells and honeycomb collagen scaffold J. Biomed. Mater. Res. A 84 2008 191 197
33. E.M. Lewiecki Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases Ther. Adv. Musculoskelet. Dis. 6 2014 48 57